The law of July 27, 2026, profoundly modifies the organization of the prevention of cardiovascular and neurovascular diseases in France. This text mandates systematic clinical and biological screening during prevention appointments and introduces a mandatory screening for familial hypercholesterolemia starting from the child’s sixth year. We are witnessing a paradigm shift: prevention moves from advice to regulatory obligation.
Early Screening for Cardiovascular Diseases: What the July 2026 Law Changes
The multiannual national strategy established by this law structures prevention around three axes: reducing inequalities in access to care, organizing care pathways, and systematically integrating awareness of risk factors during each prevention appointment.
Specifically, health professionals must now address tobacco, alcohol, sedentary lifestyle, obesity, cholesterol, diabetes, chronic kidney disease, and hypertension during these assessments. This is no longer a recommendation: it is a legislative framework.
The inclusion of familial hypercholesterolemia screening in the child’s health record is an unprecedented measure. This condition, often silent for decades, multiplies cardiovascular risk well before adulthood. We recommend that general practitioners familiarize themselves with the modalities of this biological screening, which should appear in the upcoming updates of the HAS guidelines.
To delve deeper into these topics and follow regulatory developments regarding diseases, (wo)menweb health articles regularly cover major diseases and their prevention mechanisms.
My Prevention Assessment: Structuring by Age Groups and Limits of the System
The “My Prevention Assessment” system now segments prevention consultations by age groups. The stated goal is to target the most relevant risk factors at each stage of life, rather than applying a uniform protocol.
This approach makes sense from an epidemiological standpoint. The risks associated with the developing immune system in children are entirely different from those of a 50-year-old adult exposed to cumulative cardiovascular risk factors. Segmentation allows for the adaptation of the assessment content: vaccination and psychomotor development in pediatrics, cancer and diabetes screening in adulthood, fall prevention and loss of autonomy in seniors.
However, we identify a structural limitation. The assessment remains dependent on the patient’s attendance at the consultation. Yet, the populations most at risk (precarious workers, isolated individuals, areas under-resourced in doctors) are precisely those who consult the least outside of an acute episode. Without a proactive approach, the system risks reinforcing the inequalities it aims to correct.
Environmental Risk Factors: An Underutilized Angle
Prevention assessments remain largely focused on individual behaviors. The environmental dimension (occupational exposure to carcinogenic agents, air pollution, endocrine disruptors) is not systematically integrated into the standardized questionnaire.
This is a notable gap. Occupational exposure remains a major risk factor for several cancers, and its traceability in medical records is still insufficient in primary care.
Cancer and Diabetes Prevention: Beyond Public Messaging
Primary cancer prevention relies on well-documented levers: quitting smoking, reducing alcohol consumption, regular physical activity, and balanced nutrition. These messages are well known. Their population-level effectiveness is proven.
What public articles rarely address is the issue of targeted prevention according to individual risk profiles. A patient with a BRCA mutation does not have the same cancer screening strategy as a patient without a family history. A person with a family history of type 2 diabetes requires earlier glycemic monitoring than the general population.
- Organized colorectal cancer screening through immunological testing remains underutilized despite its proven effectiveness in reducing mortality. Participation rates remain insufficient.
- Cervical cancer screening through HPV testing, recommended from age 30, is gradually replacing the cytological smear, with superior sensitivity.
- Early identification of prediabetes (fasting blood sugar between the thresholds defined by guidelines) allows for intervention on lifestyle habits before the onset of irreversible type 2 diabetes.
Immunity and Vaccination: Updating Adult Boosters
The immune system evolves with age. Immunosenescence, which refers to the gradual decline of immune defenses, justifies specific booster vaccinations for seniors: flu, shingles, pneumococcus. These vaccinations are under-prescribed.
For children, the vaccination schedule remains the foundation of infectious disease prevention. Vaccination coverage for mandatory vaccines exceeds collective immunity thresholds, but pockets of under-vaccination persist for recommended vaccines, particularly HPV among adolescents.
Prevention Research: What Happens Before Recommendations
Prevention research is not limited to clinical trials on medications. It includes interventional epidemiology, the study of social determinants of health, and the evaluation of screening programs at the population level.
Recent work on the gut microbiome opens avenues for the prevention of metabolic and autoimmune diseases. The link between microbiome composition, diet, and type 2 diabetes risk is the subject of prospective cohorts whose results should influence future nutritional recommendations.
- The One Health approach, which articulates human health, animal health, and the environment, is gaining institutional legitimacy following recent health crises related to zoonoses.
- The medico-economic evaluation of prevention programs remains an underutilized lever for arbitrating the allocation of public health resources.
- Predictive biomarkers (inflammatory, metabolic, genetic) could ultimately personalize prevention strategies, but their integration into routine practice still requires robust validations.
Disease prevention is not limited to a list of good behaviors. It relies on a changing regulatory framework, screening systems whose effectiveness depends on participation rates, and research that is gradually redefining the contours of individual risk. The shift from generic prevention to stratified prevention by risk profile is the main challenge of the coming years.
